Cubist Systematic Strategies’s Corcept Therapeutics CORT Stock Holding History

Cubist Systematic Strategies’s Portfolio CORT Stock Details CORT Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-351,374	Closed	-$8.85M	–	1669
2024 Q1	$8.85M	Buy	351,374 +118,690	+51%	+$2.99M	0.05%	297
2023 Q4	$7.56M	Sell	232,684 -55,494	-19%	-$1.8M	0.05%	322
2023 Q3	$7.85M	Buy	288,178 +188,189	+188%	+$5.13M	0.06%	311
2023 Q2	$2.22M	Sell	99,989 -4,037	-4%	-$89.8K	0.01%	841
2023 Q1	$2.25M	Sell	104,026 -159,472	-61%	-$3.45M	0.01%	1056
2022 Q4	$5.35M	Buy	263,498 +142,044	+117%	+$2.88M	0.03%	645
2022 Q3	$3.11M	Sell	121,454 -53,419	-31%	-$1.37M	0.02%	1219
2022 Q2	$4.16M	Sell	174,873 -131,139	-43%	-$3.12M	0.03%	963
2022 Q1	$6.89M	Buy	306,012 +154,184	+102%	+$3.47M	0.06%	505
2021 Q4	$3.01M	Buy	151,828 +96,570	+175%	+$1.91M	0.03%	1019
2021 Q3	$1.09M	Buy	55,258 +29,111	+111%	+$573K	0.01%	1455
2021 Q2	$575K	Buy	26,147 +17,718	+210%	+$390K	0.01%	1915
2021 Q1	$201K	Sell	8,429 -810	-9%	-$19.3K	﹤0.01%	2473
2020 Q4	$242K	Sell	9,239 -21,196	-70%	-$555K	﹤0.01%	2141
2020 Q3	$530K	Sell	30,435 -92,293	-75%	-$1.61M	0.01%	1710
2020 Q2	$2.06M	Buy	122,728 +35,085	+40%	+$590K	0.04%	775
2020 Q1	$1.04M	Sell	87,643 -13,780	-14%	-$164K	0.03%	806
2019 Q4	$1.23M	Buy	101,423 +3,847	+4%	+$46.5K	0.02%	1033
2019 Q3	$1.38M	Buy	97,576 +71,429	+273%	+$1.01M	0.03%	813
2019 Q2	$292K	Sell	26,147 -25,851	-50%	-$289K	0.01%	1822
2019 Q1	$610K	Buy	51,998 +15,619	+43%	+$183K	0.02%	1059
2018 Q4	$486K	Buy	+36,379	New	+$486K	0.02%	992
2018 Q1	–	Sell	-15,714	Closed	-$284K	–	1868
2017 Q4	$284K	Sell	15,714 -9,366	-37%	-$169K	0.02%	1285
2017 Q3	$484K	Sell	25,080 -9,517	-28%	-$184K	0.03%	846
2017 Q2	$408K	Sell	34,597 -10,623	-23%	-$125K	0.03%	850
2017 Q1	$496K	Sell	45,220 -25,663	-36%	-$281K	0.04%	643
2016 Q4	$515K	Buy	+70,883	New	+$515K	0.04%	653
2015 Q4	–	Sell	-10,311	Closed	-$39K	–	1777
2015 Q3	$39K	Buy	+10,311	New	+$39K	﹤0.01%	1742